Tullis
Venture capitalPalm Beach Gardens · 6 people tracked
Find your way into Tullis
Fund manager profile
Tullis is a venture fund manager based in Palm Beach Gardens. SEC filings show 2 venture funds on record, most recently TULLIS GROWTH FUND II, L.P. filed August 2021.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 6 people
from public directoriesWhat they invest in
from 8 of 10 portfolio companiesHealthtech ×7Biotech ×5Medical Devices ×3Digital Health ×2Crypto & Web3 ×1FemTech ×1Fintech ×1Hardware ×1
HQs:United States×10
Investments · 10 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 12022 · 12020 · 32019 · 12018 · 22015 · 110 dated
HealthtechCarlsbad, US
Terry M. Rich(Executive Officer, Director)Craig Hunsaker(Executive Officer)inJohn Allen(Executive Officer)Jeffrey Black(Executive Officer)Patrick S. Miles(Executive Officer, Director)
BoardMortimer Berkowitz III(Director)
Board seatJames L. L. Tullis· per SEC Form D · $168M raise · filed Dec 2020
electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions.
BiotechDigital HealthHardwareHealthtechMedical DevicesBasking Ridge, US
JP Errico(Executive Officer)inBrian Posner(Executive Officer)inDaniel S. Goldberger(Executive Officer, Director)Peter Staats(Director)inFrank Amato(Executive Officer)in
BoardTrevor Moody(Director)
Board seatJames L.L. TullisJames Tullis· per SEC Form D · $1.7M raise · filed Apr 2020
Co-investorsFoothill VenturesTullis Health Investors
Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression.
BiotechDigital HealthHealthtechMedical DevicesVista, US
Thierry Dervieux(Executive Officer)inWendy Swedick(Executive Officer)Fortunato R. Rocca(Executive Officer, Director)John Aballi(President & CEO)in
BoardBrian Birk(Director)
Board seatJames L.L. Tullis· per SEC Form D · $3M raise · filed Jul 2015
Co-investorsCottonwood Technology FundEPIC VENTURESH.I.G. CapitalH.I.G. HealthBridge PartnersSun Mountain CapitalTullis Health Investors
Hyperion DeFi is a U.S.
BiotechCrypto & Web3FintechHealthtechLaguna Hills, US
Michael Rowe(Executive Officer, Director)Hyunsu Jung(Chief Executive Officer)inBARRY BUTLER(Executive Officer)David(Chief Financial Officer)TSONTCHO IANCHULEV(Executive Officer, Director)
Board seatCurt LaBelle· per SEC Form D · $6M raise · filed Apr 2020
Co-investorsEshelman Ventures, LLC
BiotechSherborn, US
MARC ODRICH(Director)JONATHAN TALAMO(Director)EDWARD PARSONS(Executive Officer)SUSAN MACDONALD(Director)MICHAEL WEBB(Executive Officer, Director)
Board seatCurt Labelle· per SEC Form D · $50.3M raise · filed Oct 2022
Menlo Park, US
Fred St. Goar(Director)Shacey Petrovic(Director)Anne Morrissey(Executive Officer, Director)Phyllis Whiteley(Director)
Board seatCurt LaBelle· per SEC Form D · $12.6M raise · filed Aug 2018
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening.
FemTechHealthtechMedical DevicesMountain View, US
Donald Lee(Executive Officer)inAmelia Degenkolb(Executive Officer, Director)in
BoardLilly DeSouza Burr(Director)Rebecca Shmukler(Director)inShacey Petrovic(Director)
Board seatCurt LaBelle· per SEC Form D · $28M raise · filed Jul 2024
Co-investorsForeground CapitalLaerdal Million Lives Fund
HealthtechHunt Valley, US
Mark D'Addato(CFO and Secretary)Eugene Cattarina(CEO)
BoardNeil Ryan(Director)Christopher Krediet(Director)Curt LaBelle(Executive Officer, Director)
Board seatJames L.L. Tullis· per SEC Form D · $5.9M raise · filed Jan 2018
Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection.
BiotechHealthtechCambridge, US
Bernat Olle(Executive Officer, Director)inDaniel Couto(Executive Officer)inMark Mullikin(Executive Officer)inJeffrey Silber(Executive Officer)inChristopher Viehbacher(Director)
BoardJohn LaMattina(Director)
Board seatCurt LaBelle· per SEC Form D · $118.5M raise · filed Aug 2024
Co-investorsAMR Action FundK2 HealthVenturesSalica InvestmentsSeventure PartnersBNP ParibasBNP Paribas Asset Management Europe
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 4
IPOs and acquisitions across the tracked portfolioAlphatec HoldingsNASDAQ: ATECelectroCore, Inc.NASDAQ: ECORExagenNASDAQ: XGNHyperion DefiNASDAQ: HYPD
Portfolio news
latest coverage across their companiesAlphatec Holdings · directorstalkinterviews.com · Aug 11, 2026
Vedanta Biosciences · allsci.com · Aug 10, 2026
electroCore, Inc. · stocktitan.net · Aug 6, 2026
Exagen · gurufocus.com · Jun 25, 2026
Novocuff · businesswire.com · Sep 16, 2025
Frequently asked questions
- Where is Tullis located?
- Tullis is headquartered in Palm Beach Gardens, US.